{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Enveda raises $311 million to advance AI-assisted drug candidates","author_name":"techandbusiness.org · Startups, AI","thumbnail_url":"https://digitalmarketreports.com/wp-content/uploads/2026/04/image-140.png","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Startups, AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/b_caiwal43h70vmS9GDpBu\" style=\"color:#fff;text-decoration:none;\">Enveda raises $311 million to advance AI-assisted drug candidates</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Enveda has raised $311 million in Series E financing at a $2 billion valuation as it moves drug candidates found through its AI-assisted search of natural compounds into human testing. Catalio Capital...</p>\n    </blockquote>"}